ArticleFrontiers in cardiovascular medicine2024

Lipid-lowering drugs, circulating inflammatory factors, and atrial fibrillation: a mediation Mendelian randomization study.

Guangyang Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.